Back to search

Article

A Genome-Wide Association Study Identifying SVEP1 Variant as a Predictor of Response to Tolvaptan for Cirrhotic Ascites

2021-04-28

Abstract excerpt

<title>Abstract</title> <p>Background and Aims: Tolvaptan, an orally active vasopressin V2-receptor antagonist, has been used for patients with difficult-to-treat ascites in Japan. In this study, we conducted a genome-wide association study (GWAS) in the Japanese population to identify genetic variants associated with tolvaptan’s efficacy for patients with hepatic ascites. <h4>Methods:</h4> From 2014 through 2018...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
813d2222-fea3-55e9-93c3-2e0b7e586ae8
DOI
10.21203/rs.3.rs-388508/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Genome-Wide Association Study Identifying SVEP1 Variant as a Predictor of Response to Tolvaptan for Cirrhotic AscitesDOI 10.21203/rs.3.rs-388508/v1
Select a neighboring publication to make it the new centre.